MYC and neoplasm: Combination of OTX015 with panobinostat further significantly suppressed tumor growth/weight by 48% (compared to OTX015) and 17.6% (compared to panobinostat), suggesting the antitumor potential of OTX015 combined with panobinostat, against MYC-driven MB in vivo.